All In MedTech

Device Trial Radar · NCT04955730

NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies

Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies

Last checked: Nov 20, 2026Latest source record: Jun 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 290 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

290

Actual

Start

Aug 5, 2021

Primary completion

Apr 30, 2025

Study completion Sep 23, 2025

Sponsor

Lead sponsor
H. Lee Moffitt Cancer Center and Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 9, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections

Conditions

  • Surgical Wound Infection

Interventions

  • Negative Pressure Wound TherapyDevice

    Negative Pressure Wound Therapy is a single use NPWT that produces a negative pressure at -80 mmHg. Participants will have their fascia and skin closed in the same manner as the control arm participants, and will wear the NPWT dressing for 7 days after surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surgical Site Infection - Superficial IncisionalTime frame: 30 days post operation
  2. Surgical Site Infection - Deep IncisionalTime frame: 30 days post operation
  3. Surgical Site Infection - Organ/Space IncisionalTime frame: 30 days post operation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Moffitt Cancer Center

    Tampa, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.